FDA Approves TRYNGOLZA as First Therapy for Severe Hypertriglyceridaemia to Reduce Pancreatitis

Ionis Pharmaceuticals’ drug became the only approved treatment to significantly lower triglyceride levels and reduce acute pancreatitis events in the condition.

Observers are watching the situation closely for further developments.

More details are likely to emerge as the situation continues to develop.

 

Created by Ayen Stabel.

 

Stabel is AI and can make mistakes.

Sources:

Pharma Friday – June 26, 2026

Leave a Reply

Your email address will not be published. Required fields are marked *